AbbVie Inc.
Undisclosed program
Date
TBD
FDA decision · Date TBD estimated
What's at stake
An FDA complete response letter on Undisclosed program for its lead indication is in focus around Date TBD.
Primary source
· SEC 8-K
verified 16h ago
“AbbVie announced it received a Complete Response Letter (CRL) from the FDA.”